RVL Pharmaceuticals plc Ordinary Shares
RVLP
RVLP was delisted on the 20th of October, 2023.
66 hedge funds and large institutions have $41.1M invested in RVL Pharmaceuticals plc Ordinary Shares in 2020 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 26 increasing their positions, 16 reducing their positions, and 10 closing their positions.
63% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 16
61% more capital invested
Capital invested by funds: $25.6M → $41.1M (+$15.5M)
50% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 10
6% more funds holding
Funds holding: 62 → 66 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
DG Capital Management
New York
|
+$3.91M |
| 2 |
BlackRock
New York
|
+$1.28M |
| 3 |
GC
Globeflex Capital
San Diego,
California
|
+$481K |
| 4 |
EP
Eversept Partners
New York
|
+$387K |
| 5 |
JIC
Joel Isaacson & Co
New York
|
+$220K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SS
Sunbelt Securities
Houston,
Texas
|
-$5.03M |
| 2 |
SCM
Sio Capital Management
New York
|
-$1.83M |
| 3 |
Millennium Management
New York
|
-$1.33M |
| 4 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
-$898K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$852K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Victory Capital Management
San Antonio,
Texas
| – | -$14K | -4,682 | Closed |
|
RVLP Hedge Fund Activity: Q2 2020 in Review
66 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in RVL Pharmaceuticals plc Ordinary Shares (RVLP) for Q2 2020, worth a combined $41.1M — up 61% from $25.6M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new RVLP positions and 10 closed out — a net gain of 5 holders — while 26 added to existing stakes and 16 trimmed.
The largest buyer was DG Capital Management, opening a new position worth an estimated $3.91M. The largest seller was Sunbelt Securities, cutting an estimated $5.03M.
- 66 institutional investors held RVL Pharmaceuticals plc Ordinary Shares (RVLP) as of Q2 2020, up from 62 in Q1 2020.
- Funds reported $41.1M of RVL Pharmaceuticals plc Ordinary Shares stock for Q2 2020, up 61% quarter-over-quarter.
- 15 funds opened new RVL Pharmaceuticals plc Ordinary Shares positions in Q2 2020 and 10 closed out, a net change of +5 holders.
- The largest RVL Pharmaceuticals plc Ordinary Shares buyer in Q2 2020 was DG Capital Management, an estimated $3.91M added.
- The largest RVL Pharmaceuticals plc Ordinary Shares seller in Q2 2020 was Sunbelt Securities, an estimated $5.03M sold.
Based on aggregated 13F filings for Q2 2020.